Safety Assessment of Fatty Acids & Soaps As Used in Cosmetics
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Calcium Stearate Processing
National Organic Standards Board Technical Advisory Panel (TAP) Review Compiled by University of California Sustainable Agriculture Research and Education Program (UC SAREP) for the USDA National Organic Program Calcium Stearate Processing Executive Summary1 A petition is under consideration with respect to NOP regulations subpart G §205.605, governing the use of substances in processed products: Petitioned: Inclusion of calcium stearate on National List of nonagricultural substances allowed in or on processed products labeled as “organic” or “made with organic (specified ingredients or food group(s)).” Calcium stearate is a compound of calcium with a mixture of solid organic acids obtained from edible sources. It is generally used as a solid-phase lubricant that reduces friction between particles of the substance to which it is added. The Petitioner’s intended use is “as a flow agent (anti-dusting agent)” to be used in dry flour based ingredients sold to bakeries (NOSB Petition). The NOP has no prior listing or ruling on the substance. All three reviewers agreed that the substance should be considered synthetic. The reviewers were divided over the use of calcium stearate in food labeled as “organic.” Two of the reviewers felt it should not be allowed in these foods, while one reviewer felt it should be accepted. One reviewer who voted to restrict its use indicated that more information was needed on the nature of the substance and its potential applications, and the other reviewer felt that inclusion of a “synthetic” substance in organics runs contrary to consumer’s expectations regarding organic products. All three reviewers agreed that the substance should be allowed in products labeled as “made with organic…” ingredients. -
The Effect of Water Hardness on Surfactant Deposition After Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects
This is a repository copy of The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects . White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/120644/ Version: Published Version Article: Danby, S.G. orcid.org/0000-0001-7363-140X, Brown, K., Wigley, A. et al. (4 more authors) (2018) The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects. Journal of Investigative Dermatology, 138 (1). pp. 68-77. ISSN 0022-202X https://doi.org/10.1016/j.jid.2017.08.037 Reuse This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long as you credit the authors, but you can’t change the article in any way or use it commercially. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ ORIGINAL ARTICLE The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects Simon G. Danby1, Kirsty Brown1, Andrew M. Wigley1, John Chittock1, Phyoe K. -
Metallic Soap Fine Particles, Process for Producing Same and Use of Same
Patentamt Europaisches ||| || 1 1| || || || ||| || || ||| || || 1 1| (19) J European Patent Office Office europeen des brevets (11) EP 0 902 005 A2 (12) EUROPEAN PATENT APPLICATION Date of (43) publication: (51) |nt. CI.6: C07C 53/126, C07C 51/41 , 17.03.1999 Bulletin 1999/11 C07C 57/12, G03G 9/097, (21 ) Application number: 981 1 701 1 .1 G03G 5/00 (22) Date of filing: 09.09.1998 (84) Designated Contracting States: (72) Inventors: AT BE CH CY DE DK ES Fl FR GB GR IE IT LI LU • Sawada, Kouhei MC NL PT SE Nishinomiya-shi, Hyogo-ken (JP) Designated Extension States: • Nakamura, Shinji AL LT LV MK RO SI Nishinomiya-shi, Hyogo-ken (JP) • Onodera, Show (30) Priority: 1 1 .09.1997 JP 24721 1/97 Nishinomiya-shi, Hyogo-ken (JP) 20.03.1998 JP 72813/98 20.03.1998 JP 72815/98 (74) Representative: 20.03.1998 JP 72816/98 Leifert, Elmar, Dr. Bohm Rauch Schumacher (71 ) Applicant: NOF CORPORATION Kramer & Leifert Tokyo (JP) Burgplatz 21 -22 40213 Dusseldorf (DE) (54) Metallic soap fine particles, process for producing same and use of same (57) There are disclosed metallic soap fine particles ture to form a slurry of the metallic soap, and drying the which have an average particle size of 4 urn or smaller resultant slurry at a specific temperature. The metallic and have a content of particles having particle sizes of soap, which has remarkably fine particles and narrow 1 0 urn or larger of at most 4% by weight based on the particle size distribution, is well suited for use e.g. -
Magnesium Stearate
United States Department of Agriculture Agricultural Marketing Service | National Organic Program Document Cover Sheet https://www.ams.usda.gov/rules-regulations/organic/national-list/petitioned Document Type: ☐ National List Petition or Petition Update A petition is a request to amend the USDA National Organic Program’s National List of Allowed and Prohibited Substances (National List). Any person may submit a petition to have a substance evaluated by the National Organic Standards Board (7 CFR 205.607(a)). Guidelines for submitting a petition are available in the NOP Handbook as NOP 3011, National List Petition Guidelines. Petitions are posted for the public on the NOP website for Petitioned Substances. ☒ Technical Report A technical report is developed in response to a petition to amend the National List. Reports are also developed to assist in the review of substances that are already on the National List. Technical reports are completed by third-party contractors and are available to the public on the NOP website for Petitioned Substances. Contractor names and dates completed are available in the report. Magnesium Stearate Handling/Processing 1 2 Identification of Petitioned Substance 13 3 Chemical Names: 14 Trade Names: 4 Magnesium stearate 15 N/A 5 Octadecanoic acid magnesium salt 6 Magnesium octadecanoate CAS Numbers: 7 557-04-0 8 Other Name: 9 Stearic acid magnesium salt 10 Magnesium distearate Other Codes: 11 EC-No. 209-150-3 12 INS No. 470(iii) 16 17 Summary of Petitioned Use 18 Magnesium stearate is used as a lubricant or anticaking agent in food processing and handling. Magnesium 19 stearate is currently listed on the National List of Allowed and Prohibited Substances as a synthetic 20 nonagricultural (nonorganic) substance allowed as ingredients in or on processed products labeled as “organic” 21 or “made with organic (specified ingredients or food group(s))” (7 Code of Federal Regulation (CFR) 205.605(b)). -
Alpha-Linolenic Acid COMMON NAME: ALA Omega-3
Supplements to help manage total cholesterol, LDL and HDL Alpha-Linolenic Acid COMMON NAME: ALA omega-3 SCIENTIFIC NAME: ALA, 18:3 n-3 RECOMMENDED WITH CAUTION LEVELS OF EVIDENCE 1 2 Recommended: Recommended with Caution: Several well-designed studies in humans Preliminary studies suggest some benefit. have shown positive benefit. Our team is Future trials are needed before we can confident about its therapeutic potential. make a stronger recommendation. 3 4 Not Recommended - Evidence: Not Recommended - High Risk: Our team does not recommend this Our team recommends against using this product because clinical trials to date product because clinical trials to date suggest little or no benefit. suggest substantial risk greater than the benefit. Evaluated Benefits Reduces total cholesterol, LDL cholesterol, and triglycerides Supported by P&G HeartHealth-RecommendedWithCaution.indd 1 6/27/2017 9:41:39 AM Source Dietary alpha-linolenic acid is found primarily in vegetable oils, such as flaxseed (linseed) oil and canola (rapeseed) oil. Walnuts are the only edible nuts with significant amounts of alpha-linolenic acid. Alpha-linolenic acid is found in smaller amounts in green leafy vegetables and chocolate. ALA is an essential fatty acid that must be consumed for you to have any in your body. Indications/Population Lowering of LDL cholesterol/hyperlipidemia and metabolic syndrome Mechanism of Action It may increase insulin sensitivity directly, or decrease hepatic fat storage. Some (2–15%) is convert- ed to eicosapentaenoic acid (EPA), and less (<2%) to docosahexaenoic acid (DHA). The effects of ALA on serum lipids were, for the most part, not consistent with that reported for the very long-chain omega-3 fatty acids, EPA and DHA. -
Fruits of the Pitahaya Hylocereus Undatus and H. Ocamponis
Journal of Applied Botany and Food Quality 93, 197 - 203 (2020), DOI:10.5073/JABFQ.2020.093.024 1Instituto de Horticultura, Departamento de Fitotecnia. Universidad Autónoma Chapingo, Estado de Mexico 2Instituto de Alimentos, Departmento de Ingenieria Agroindustrial. Universidad Autónoma Chapingo, Estado de Mexico Fruits of the pitahaya Hylocereus undatus and H. ocamponis: nutritional components and antioxidants Lyzbeth Hernández-Ramos1, María del Rosario García-Mateos1*, Ana María Castillo-González1, Carmen Ybarra-Moncada2, Raúl Nieto-Ángel1 (Submitted: May 2, 2020; Accepted: September 15, 2020) Summary epicarp of bracts. In addition, it is important to point out that “pitaya” The pitahaya (Hylocereus spp.) is a cactus native to America. and “pitahaya” have been used incorrectly as synonyms (IBRAHIM Despite the great diversity of species located in Mexico, there are et al., 2018; LE BELLEC et al., 2006). “Pitaya” corresponds to the few studies on the nutritional and nutraceutical value of its exotic genus Stenocereus (QUIROZ-GONZÁLEZ et al., 2018), while “pitahaya” fruits, ancestrally consumed in the Mayan culture. An evaluation was corresponds to the genus Hylocereus (WU et al., 2006). Research on made regarding the physical-chemical characteristics, the nutritional pitahaya was done in this study. components and the antioxidants of the fruits of H. ocamponis The fruit of H. ocamponis (Salm-Dyck) Britton & Rose, known as (mesocarp or red pulp) and H. undatus (white pulp), species of great pitahaya solferina (red epicarp, red, pink or purple mesocarp) is a native commercial importance. The pulp of the fruits presented nutritional species of Mexico (GARCÍA-RUBIO et al., 2015), little documented, and nutraceutical differences between both species. -
U.S. EPA, Pesticide Product Label, GLD GERMICIDAL LIQUID DETERGENT, 10/20/1969
, . , , ~ , 0' • . 41 , ~ -, - • ... ~ ~ • e. ... .. • ~l D I~ :~d :. -:, ~ a modern BROAD SPEC· -= -I a,' Germicidal Cleaner for· •.. -- ~:sj specifically to CLEAN. .~ I ~ re" Ita :5!~,;:ECT, and DEODORIZE !!ETERGENT t u ra I t BACTERICIDAL T~~'" ~ ~ }OAL FUNGICIDAL tlons -s":": ::::""'tly in a single opera+ion. ,,11 ';;"-~ /I~ - e:-;/ effective in killing most cJe<.UU • ~,W'... .IJ# • 5"':: -,0 -,egative and gram-positive U.S.D.A. REGI~i,.~H~N NO. 2311 4 ,,,. '1 , '. II Ph~nol COE:ffic;er,~s: A.O.A.C. f.'\Cth00 _1~~1 t - ,_ . I ',-' - :"'Dcrganisms, and odor pro : ' I Sulmonello typhosa 6.;) AOA.C Use 2 =-: ~g bacteria, in particular Stuphylococcus aureus 75 ,t'.OAC • J . ' !-',." J V 5·::~;E; ... S. S-typhosa, E-coli, S-py o Lise dilution confirmatia;), t· ().!\ C t~~tr,:~,! lOtrl Editi'Jn - '.I ' I ; 0 S : Saln"'Jvnella chuleraesuis 1 ~ : f.", 0 ~E;-'E=S, M-smegmatis, S-schott 0 ..... I\~ycobacterium tubercuicsis var. b -. .' \- ~ ~ 1 :65 Use 3 - - s; Ie r . S- pa radysenteriae, S ACTIVE INGREDIENTS ........... 0 . 0 0 .28.180/0 INERT INGREDIENTS . 071.82% water. : -: leraesuis, and fungi. When potassium laurate, potassium myristate, iso water, glycerine, trisodium propyl alcohol, ortho·benzyl·para-chlorophellol, phosphate, sodium tetrabor Appl~ ~ :.·"ed to dry without rinsing it trietha nola mi ne linea r dodecyl benzene su Ifon 0 ate. coconut diethanolamide. thorOl -:arts a residual bacteriostatic ate, tetrasodium ethylenediamine tetraacetate. and di .: - to :he surface. CAUTION: Keep Out Of Reach Of Children t " ' ~J:E:ilE="': deodorant for use In Harmful if swallowed. Antidote: Milk or Raw Egg-Call Physician. -
Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders—A Review
nutrients Review Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders—A Review Ewa Sokoła-Wysocza ´nska 1, Tomasz Wysocza ´nski 2, Jolanta Wagner 2,3, Katarzyna Czyz˙ 4,*, Robert Bodkowski 4, Stanisław Lochy ´nski 3,5 and Bozena˙ Patkowska-Sokoła 4 1 The Lumina Cordis Foundation, Szymanowskiego Street 2/a, 51-609 Wroclaw, Poland; [email protected] 2 FLC Pharma Ltd., Wroclaw Technology Park Muchoborska Street 18, 54-424 Wroclaw, Poland; [email protected] (T.W.); jolanta.pekala@flcpharma.com (J.W.) 3 Department of Bioorganic Chemistry, Faculty of Chemistry, University of Technology, Wybrzeze Wyspianskiego Street 27, 50-370 Wroclaw, Poland; [email protected] 4 Institute of Animal Breeding, Faculty of Biology and Animal Sciences, Wroclaw University of Environmental and Life Sciences, Chelmonskiego Street 38c, 50-001 Wroclaw, Poland; [email protected] (R.B.); [email protected] (B.P.-S.) 5 Institute of Cosmetology, Wroclaw College of Physiotherapy, Kosciuszki 4 Street, 50-038 Wroclaw, Poland * Correspondence: [email protected]; Tel.: +48-71-320-5781 Received: 23 August 2018; Accepted: 19 October 2018; Published: 21 October 2018 Abstract: Cardiovascular diseases are described as the leading cause of morbidity and mortality in modern societies. Therefore, the importance of cardiovascular diseases prevention is widely reflected in the increasing number of reports on the topic among the key scientific research efforts of the recent period. The importance of essential fatty acids (EFAs) has been recognized in the fields of cardiac science and cardiac medicine, with the significant effects of various fatty acids having been confirmed by experimental studies. -
Lubricants in Pharmaceutical Solid Dosage Forms
Lubricants 2014, 2, 21-43; doi:10.3390/lubricants2010021 OPEN ACCESS lubricants ISSN 2075-4442 www.mdpi.com/journal/lubricants Review Lubricants in Pharmaceutical Solid Dosage Forms Jinjiang Li * and Yongmei Wu Drug Product Science & Technology, Bristol-Myers Squibb Corporation, 1 Squibb Dr., New Brunswick, NJ 08903, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-732-227-6584; Fax: +1-732-227-3784. Received: 18 December 2013; in revised form: 21 January 2014 / Accepted: 24 January 2014 / Published: 25 February 2014 Abstract: Lubrication plays a key role in successful manufacturing of pharmaceutical solid dosage forms; lubricants are essential ingredients in robust formulations to achieve this. Although many failures in pharmaceutical manufacturing operations are caused by issues related to lubrication, in general, lubricants do not gain adequate attention in the development of pharmaceutical formulations. In this paper, the fundamental background on lubrication is introduced, in which the relationships between lubrication and friction/adhesion forces are discussed. Then, the application of lubrication in the development of pharmaceutical products and manufacturing processes is discussed with an emphasis on magnesium stearate. In particular, the effect of its hydration state (anhydrate, monohydrate, dihydrate, and trihydrate) and its powder characteristics on lubrication efficiency, as well as product and process performance is summarized. In addition, the impact of lubrication on the dynamics of compaction/compression processes and on the mechanical properties of compacts/tablets is presented. Furthermore, the online monitoring of magnesium stearate in a blending process is briefly mentioned. Finally, the chemical compatibility of active pharmaceutical ingredient (API) with magnesium stearate and its reactive impurities is reviewed with examples from the literature illustrating the various reaction mechanisms involved. -
Omega-3, Omega-6 and Omega-9 Fatty Acids
Johnson and Bradford, J Glycomics Lipidomics 2014, 4:4 DOI: 0.4172/2153-0637.1000123 Journal of Glycomics & Lipidomics Review Article Open Access Omega-3, Omega-6 and Omega-9 Fatty Acids: Implications for Cardiovascular and Other Diseases Melissa Johnson1* and Chastity Bradford2 1College of Agriculture, Environment and Nutrition Sciences, Tuskegee University, Tuskegee, Alabama, USA 2Department of Biology, Tuskegee University, Tuskegee, Alabama, USA Abstract The relationship between diet and disease has long been established, with epidemiological and clinical evidence affirming the role of certain dietary fatty acid classes in disease pathogenesis. Within the same class, different fatty acids may exhibit beneficial or deleterious effects, with implications on disease progression or prevention. In conjunction with other fatty acids and lipids, the omega-3, -6 and -9 fatty acids make up the lipidome, and with the conversion and storage of excess carbohydrates into fats, transcendence of the glycome into the lipidome occurs. The essential omega-3 fatty acids are typically associated with initiating anti-inflammatory responses, while omega-6 fatty acids are associated with pro-inflammatory responses. Non-essential, omega-9 fatty acids serve as necessary components for other metabolic pathways, which may affect disease risk. These fatty acids which act as independent, yet synergistic lipid moieties that interact with other biomolecules within the cellular ecosystem epitomize the critical role of these fatty acids in homeostasis and overall health. This review focuses on the functional roles and potential mechanisms of omega-3, omega-6 and omega-9 fatty acids in regard to inflammation and disease pathogenesis. A particular emphasis is placed on cardiovascular disease, the leading cause of morbidity and mortality in the United States. -
Synthesis, Characterization and Permofarmance Activity of Metal Soap of Calcium, Cobalt, Iron and Copper from Palm Kernel Oil As a Drier in Paint
Advances in Bioscience and Bioengineering 2016; 4(6): 85-90 http://www.sciencepublishinggroup.com/j/abb doi: 10.11648/j.abb.20160406.14 ISSN: 2330-4154 (Print); ISSN: 2330-4162 (Online) Synthesis, Characterization and Permofarmance Activity of Metal Soap of Calcium, Cobalt, Iron and Copper from Palm Kernel Oil as a Drier in Paint Eluchie Nene Pearl Biotechnology and Energy Research, Ministry of Science and Technology, Umuahia, Nigeria Email address: [email protected], [email protected] To cite this article: Eluchie Nene Pearl. Synthesis, Characterization and Permofarmance Activity of Metal Soap of Calcium, Cobalt, Iron and Copper from Palm Kernel Oil as a Drier in Paint. Advances in Bioscience and Bioengineering. Vol. 4, No. 6, 2016, pp. 85-90. doi: 10.11648/j.abb.20160406.14 Received: October 21, 2016; Accepted: November 12, 2016; Published: December 6, 2016 Abstract: The behavior of Palm Kernel Oil was saponified by potassium hydroxide to form soluble soap which was later reacted with solutions of copper, cobalt, Iron and calcium to produce the metal soaps which were used as drier in coating mixture (Paint). The performance of these metal soaps has been studied. The effect of environmental and corrosive factors on paints was also studied. From the study, the formulated paint samples using metal soap had low specific gravity (1.45-1.47). This is an indication that more metal soap can be incorporated into the paint. Full hardness of paint samples was within the range (0.38-0.41mm) which implies that the samples will have high tolerance to anti-corrosive coating. The paints showed strong adhesion properties that are capable to withstand abrasive and corrosive agents. -
Interagency Committee on Chemical Management
DECEMBER 14, 2018 INTERAGENCY COMMITTEE ON CHEMICAL MANAGEMENT EXECUTIVE ORDER NO. 13-17 REPORT TO THE GOVERNOR WALKE, PETER Table of Contents Executive Summary ...................................................................................................................... 2 I. Introduction .......................................................................................................................... 3 II. Recommended Statutory Amendments or Regulatory Changes to Existing Recordkeeping and Reporting Requirements that are Required to Facilitate Assessment of Risks to Human Health and the Environment Posed by Chemical Use in the State ............................................................................................................................ 5 III. Summary of Chemical Use in the State Based on Reported Chemical Inventories....... 8 IV. Summary of Identified Risks to Human Health and the Environment from Reported Chemical Inventories ........................................................................................................... 9 V. Summary of any change under Federal Statute or Rule affecting the Regulation of Chemicals in the State ....................................................................................................... 12 VI. Recommended Legislative or Regulatory Action to Reduce Risks to Human Health and the Environment from Regulated and Unregulated Chemicals of Emerging Concern ..............................................................................................................................